Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Alzheimer's Disease Health Center

Font Size

Blood Marker Predicts Alzheimer's

Triple Alzheimer's Risk With High Blood Level of Plaque Peptide
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 8, 2008 -- High blood levels of a plaque peptide may predict Alzheimer's disease in elderly people.

The finding comes from a study of 1,125 people who were in their late 70s when their blood was first tested. Four and a half years later, 104 of them had Alzheimer's disease.

Those with the highest blood levels of A-beta 42, a major component of the plaque that clogs the brains of Alzheimer's patients, were far more likely to get Alzheimer's than were those with the lowest A-beta 42 levels.

"Compared with individuals with low [blood] A-beta 42 levels at baseline, those with high A-beta 42 levels had more than a threefold increased risk of developing Alzheimer's disease over an average of 4.5 years," conclude Columbia University researcher Nicole Schupf, PhD, DrPH, and colleagues.

Interestingly, just before study participants developed the first signs of Alzheimer's disease, their A-beta 42 blood levels suddenly dropped. This, the researchers suggest, is a sensitive sign that a person has recently developed Alzheimer's.

Different studies of plaque peptides in the blood have come up with different results. Timing may have everything to do with this, Schupf and colleagues suggest.

When tested well before symptoms appear, the study suggests, people on the road to Alzheimer's will have high levels of A-beta in their blood. But when they finally get Alzheimer's, A-beta 42 sticks in the brain -- and blood levels drop.

The study also shows that blood levels of a second plaque peptide, A-beta 40, are not higher in people who eventually develop Alzheimer's disease.

The researchers say more work is needed to detail the patterns of change in A-beta levels and to see whether these patterns differ in people with genetic and environmental risk factors for Alzheimer's.

Schupf and colleagues report their findings in the Sept. 16 issue of Proceedings of the National Academy of Sciences.

Today on WebMD

Remember your finger
When it’s more than just forgetfulness.
senior man with serious expression
Which kinds are treatable?
senior man
Common symptoms to look for.
mri scan of human brain
Can drinking red wine reverse the disease?
eating blueberries
Colored mri of brain
Close up of elderly couple holding hands
mature woman
Woman comforting ailing mother
Senior woman with serious expression